Interferón alfa 2b recombinante más ribavirina en el tratamiento de la hepatitis crónica C Recombinant Interferon alfa-2b plus Ribavirin in treatment of chronic hepatitis C

by Yoan Antonio Sánchez Rodríguez, Enrique Arús Soler, Bienvenido Grá Oramas, Pedro López Saura, Hugo Nodarse Cuní
Published 2010-06-01

Epidermal growth factor in the treatment of radiogenic proctitis

by Nery González, Francisco Hernández-Bernal, Tania González, Josefina Lugo, Juan J Lence, Maria A Pascual, Pedro López-Saura

Tratamiento de la hepatitis crónica C con interferón alfa 2b recombinante: Ensayo clínico controlado aleatorizado

by Enrique Arús Soler, Luis Rivera Reimón, Anayda Fernández Naranjo, Mirtha Infante Velázquez, Rafael Jorge Díaz, Grisel Soto Argüelles, Pedro López Saura, Bienvenido Gra Oramas
Published 2000-03-01

Tratamiento de la hepatitis viral aguda c con interferón alfa 2b recombinante: Ensayo clínico

by Enrique Arús Soler, Luis Rivera Reimón, Mirtha Infante Velázquez, Marlen Pérez Lorenzo, Grisel Soto Argüelles, Bievenido Gra Oramas, Guillermo Padrón González, Pedro López Saura
Published 2000-03-01

Interferón gamma recombinante como alternativa terapéutica en niños con artritis idiopática juvenil Recombinant gamma Interferon as a therapeutical alternative in children with juv...

by Cecilia Coto Hermosilla, Idrian García García, Gisou Díaz Rojo, Iraldo Bello Rivero, Cimara Bermudez Badell, Gloria Valera Puente, Dolores Cantero Oceguera, Víctor Hernández González, Melba Méndez Méndez, Santa Gómez Conde, Hugo Nodarse Cuní, Pedro López Saura
Published 2010-03-01

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers

by Marisa Boff Costa, Paulo Dornelles Picon, Guilherme Becker Sander, Hugo Nodarse Cuni, Carmen Valenzuela Silva, Rolando Páez Meireles, Ana Carolina Magalhães Andrade Góes, Nadia Maria Batoreu, Maria de Lourdes de Sousa Maia, Elizabeth Maciel Albuquerque, Denise Cristina de Souza Matos, Pedro Lopez Saura
Published 2018-01-01

Interferon alpha-2b and ribavirin as combined therapy for chronic hepatitis C in Cuba: National Program

by Hugo Nodarse-Cuní, Enrique Arús-Soler, Luis L Rivera-Reimón, Marlén Pérez-Lorenzo, Marcia Samada-Suárez, Waldo O García-Ferrera, Yoan A Sánchez-Rodríguez, Daymela Pupo-Oliveros, Angel Obregón-Moreno, Ivis Umpierre-García, Orelvis Martínez-Martínez, Antonio Moret-Pérez, Yaimé González-González, Yuliet Bermúdez-Hernández, Elizeth García-Iglesias, Odalys C Lazo-Diago, Pedro López-Saura

Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac

by Jesús A. Junco, Ranfis Rodríguez, Franklin Fuentes, Idania Baladrón, Maria D. Castro, Lesvia Calzada, Carmen Valenzuela, Eddy Bover, Eulogio Pimentel, Roberto Basulto, Niurka Arteaga, Angel Cid-Arregui, Francisco Sariol, Lourdes González, Liliana Porres-Fong, María Medina, Ayni Rodríguez, A. Hilda Garay, Osvaldo Reyes, Matilde López, Lourdes de Quesada, Allelin Alvarez, Carolina Martínez, Marleny Marrero, Guillermo Molero, Alfredo Guerra, Pedro Rosales, Carlos Capote, Sahily Acosta, Idania Vela, Lina Arzuaga, Ana Campal, Erlán Ruiz, Elier Rubio, Pável Cedeño, María Carmen Sánchez, Pedro Cardoso, Rolando Morán, Yairis Fernández, Magalys Campos, Henio Touduri, Dania Bacardi, Indalecio Feria, Amilcar Ramirez, Karelia Cosme, Pedro López Saura, Maricel Quintana, Verena Muzio, Ricardo Bringas, Marta Ayala, Mario Mendoza, Luis E. Fernández, Adriana Carr, Luis Herrera, Luis Herrera, Gerardo Guillén
Published 2019-02-01